US 12186324
Imidazopiperazine inhibitors of transcription activating proteins
granted A61KA61K31/4985A61K31/5377
Quick answer
US patent 12186324 (Imidazopiperazine inhibitors of transcription activating proteins) held by The Board of Regents of the University of Texas System expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/4985, A61K31/5377